Jacqueline Fernandez appears before Delhi Police in Sukesh extortion case

Bollywood actor Jacqueline Fernandez on Wednesday appeared before Delhi Police's Economic Offences Wing in connection with an extortion case linked to alleged conman Sukesh Chandrashekhar, officials said. Fernandez, a Sri Lankan national, joined the probe after being issued a third summons, they said. The actor was accompanied by Pinki Irani who allegedly introduced her to Chandrashekhar, a senior police officer said. The "Housefull 3" actor had been asked to join the probe on Monday but cited prior commitments and sought another date. Earlier this month, another Bollywood actor, Norah Fatehi, was questioned by the agency got six to seven hours in the case and her statement recorded. Chandrashekhar, who is currently in jail, is accused of cheating various people, including high-profile individuals such as former Fortis Healthcare promoter Shivinder Mohan Singh's wife Aditi Singh. Fatehi was earlier questioned by the Enforcement Directorate (ED) in the case. On August 17, the ED
14-09-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

This is in continuation of our earlier intimation ref. no. FHL/SEC/2021-22 dated January 10, 2022, in relation to the suit / complaint filed by M/s. Emqore Envesecure Private Capital Trust ('Emqore') against 28 named defendants and 21 non-party defendants, including Fortis Healthcare Limited ('FHL') and IHH Healthcare Berhad ('IHH'), the holding company of Northern TK Venture Pte Ltd. (''the Promoter of FHL''), before the United States District Court, District of New Jersey, USA. The Complaint has never been served on FHL under the Hague Convention on the Service Abroad of Judicial and Extrajudicial Documents in Civil or Commercial Matters ('Hague Convention'). The detailed disclosure in this regard is attached.
09-09-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming Analysts' / Institutional Investors' Meeting with the Management of the Company: Date: September 7, 2022 Investors / Analysts / Events: Ashwamedh - Elara India Dialogue 2022 - Investor Conference Location: Mumbai No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investor conference. This is for your kind information and record.
05-09-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming Analyst / Institutional Investor Meetings with the Management of the Company: Date & Time : August 23, 2022 (02:00 PM) and August 24, 2022 (04:00 PM) Investors / Analysts / Events: DAM Capital Mid-Cap Investor Conference Location: Virtual Conference
22-08-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements published on August 19, 2022 in the columns of English daily 'Financial Express', all editions and Punjabi daily 'Rozana Spokesman', Mohali edition, inter-alia, intimating completion of the electronic transmission of Postal Ballot Notice along with the Postal Ballot Form to the Members. This is for your information and record.
19-08-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you that the Company has completed dispatch of postal ballot notice to its members on August 18, 2022 for seeking their approval by way of Special Resolution on following proposals: a) To consider amalgamation of Fortis Asia Healthcare Pte Limited (''FAHPL'') and Fortis Healthcare International Pte Limited (''FHIPL''), step-down subsidiaries of the Company, including conversion of outstanding intercorporate loan into redeemable preference shares and amendment in terms of the existing redeemable preference shares of FAHPL; and b) To consider acquisition of Land and Building adjacent to Fortis Hospital, Anandpur, Kolkata by way of transfer of license to International Hospital Limited, a subsidiary of the Company from Artistery Properties Private Limited. Further, a copy of the Postal Ballot Notice along with Ballot Form is enclosed for kind reference.
18-08-2022

Covid: Delhi sees nearly two-fold rise in hospitalisations in fortnight

Amid a spike in COVID-19 cases in the national capital, there has been a nearly two-fold increase in hospitalisations in over a fortnight, with officials saying those with comorbidities are getting admitted to hospitals. Even though the rise in infections and hospitalisations is not yet alarming, experts have reiterated the need to wear masks and follow Covid-appropriate behaviour. Of the 9,405 available beds for coronavirus patients in Delhi, 307 (3.26 per cent) were occupied on August 1. The occupancy rate was 3.75 per cent on August 2 and four per cent the day after. It kept on rising on most days thereafter and stood at 6.24 per cent on August 16. The bed occupancy rate was five per cent on August 6 and 5.97 per cent on August 11. The occupancy rate was 6.13 per cent on August 12 and declined marginally to 5.99 per cent the next day. It rose to 6.21 per cent on August 14 and stood at 6.31 per cent on August 15. Dr Vikas Maurya, Director and HOD, Pulmonology, Fortis Hospital...
17-08-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Transcript of the investors / analysts meet held on August 8, 2022 to discuss the Company's un-audited financial results for the quarter ended June 30, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors. This is for your kind information and record.
11-08-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the investors / analysts meet held on August 8, 2022 to discuss the Company's un-audited financial results for the quarter ended June 30, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors. This is for your kind information and record.
09-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Fortis Healthcare Ltd.

Fortis Healthcare announced Q1FY23 Result : Consolidated revenues of the company grew 5.5% versus Q1FY22 and 8% versus Q4 FY22 Hospital business witnessed robust performance - revenue grows 18.5% versus Q1FY22 and 14.6% versus Q4FY22 Hospital EBITDA grew 39% YoY to INR 208 Crs, translating into a 17.4% margin Hospital business EBITDA contribution to consolidated EBITDA increases to 76% versus 53% in Q1 FY22 ARPOB at INR 1.96 Crs, up 21%. Surgical : non-surgical mix at an all time high of 61 :39 Diagnostics business witnessed muted performance due to lower covid volumes; margins at 19.3% Healthy Balance Sheet – net debt to EBITDA at 0.54x, net debt at INR 585 Crs. Ravi Rajagopal, Chairman, Board of Directors, Fortis Healthcare stated, “Q1 FY23 has witnessed an encouraging start to the fiscal. With covid abating, our hospital business has shown a strong uptrend relative to the diagnostics business which has seen a decline in volumes due to a higher covid led base in both Q1 and Q4 of FY22. We continue to further strengthen the business in terms of adding beds, expanding medical programs, and onboarding clinical talent. Our next phase of growth would be led by our brownfield expansion strategy which would see approx. 1500 beds coming onstream in the next few years: largely in key existing Fortis facilities such as the likes of FMRI, Mohali, Shalimar Bagh, BG Road and Noida. This coupled with our focus on digital initiatives in both the medical and non-medical related aspects should enable us to further fortify our longer-term business prospects” Result PDF
08-08-2022
Next Page
Close

Let's Open Free Demat Account